Finance

Lists
CBHD:ETR
Coloplast A/S
€55.68
-0.54%
(-0.30) 1D
Sep 30, 5:35:46 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CBHD...
Open
€56.16
High
€56.44
Low
€55.68
Mkt. cap
88.07B
Avg. vol.
1.68K
Volume
251.00
52-wk high
€84.34
52-wk low
€49.48
No. of employees
17K
Open
€56.16
High
€56.44
Low
€55.68
Mkt. cap
88.07B
Avg. vol.
1.68K
Volume
251.00
52-wk high
€84.34
52-wk low
€49.48
No. of employees
17K
News stories
From web sources and news partners
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast A/S
CEO-
Employees17.2K
Founded1957
HeadquartersHumlebaek, Capital Region of Denmark, Denmark
SectorMedical device
Websitecoloplast.com
Last report
Aug 18, 2026
Fiscal period
Q3 2026
EPS / Est. (DKK)
- / DKK 6.06
Revenue / Est. (DKK)
7.36B / 7.27B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.96B
7.04B
7.08B
7.36B
Cost of goods sold
2.20B
2.31B
2.37B
2.45B
Cost of revenue
2.20B
2.31B
2.37B
2.45B
Research and development expenses
249.00M
247.00M
254.00M
281.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62B
2.64B
2.67B
2.72B
Operating expense
2.79B
2.88B
2.90B
2.98B
Total operating expenses
4.99B
5.19B
5.26B
5.43B
Operating income
1.97B
1.85B
1.82B
1.93B
Other non operating income
-6.00M
42.00M
-188.00M
-
EBT including unusual items
1.56B
1.79B
-1.24B
1.87B
EBT excluding unusual items
1.81B
1.83B
1.78B
1.89B
Income tax expense
680.00M
394.00M
-273.00M
412.00M
Effective tax rate
43.73%
22.00%
21.95%
21.98%
Other operating expenses
-80.00M
-6.00M
-23.00M
-25.00M
Net income
875.00M
1.40B
-971.00M
1.46B
Net profit margin
12.57%
19.84%
-13.71%
19.88%
Earnings per share
4.67
-
6.16
-
Interest and investment income
22.00M
32.00M
149.00M
169.00M
Interest expense
-152.00M
-164.00M
-
-206.00M
Net interest expenses
-130.00M
-132.00M
149.00M
-37.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.20B
2.20B
2.17B
2.29B
Gain or loss from assets sale
2.00M
-
1.00M
-5.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps